Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

S. Alonso, M. Riveiro-Barciela, I. Fernandez, D. Rincón, Y. Real, S. Llerena, F. Gea, A. Olveira, C. Fernandez-Carrillo, B. Polo, J. A. Carrión, A. Gómez, M. J. Devesa, C. Baliellas, Castro, J. Ampuero, R. Granados, J. M. Pascasio, A. Rubín, J. SalmeronE. Badia, J. M.M. Planas, S. Lens, J. Turnes, J. L. Montero, M. Buti, R. Esteban, C. M. Fernández-Rodríguez

Research output: Contribution to journalArticleResearchpeer-review

31 Citations (Scopus)

Fingerprint Dive into the research topics of 'Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort'. Together they form a unique fingerprint.

Medicine & Life Sciences